Synergistic activity of ceftazidime-avibactam and aztreonam against serine and metallo-β-lactamase-producing gram-negative pathogens

Diagnostic Microbiology and Infectious Disease

Volumn 88, Issue 4, 2017, Pages 352-354

  Wenzler, Eric ^a   Deraedt, Matthew F ^a   Harrington, Amanda T ^a   Danizger, Larry H ^a,b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY OF ILLINOIS   (United States)

Author keywords

Avibactam; Aztreonam; beta Lactamase; Carbapenemase; Ceftazidime; Etest; Synergy

Indexed keywords

AVIBACTAM PLUS CEFTAZIDIME; AZTREONAM; CEFTAZIDIME; METALLO BETA LACTAMASE; SERINE; ANTIINFECTIVE AGENT; AVIBACTAM, CEFTAZIDIME DRUG COMBINATION; AZABICYCLO DERIVATIVE; BETA LACTAMASE;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CITROBACTER FREUNDII; CONTROLLED STUDY; DRUG ACTIVITY; DRUG POTENTIATION; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE; EPSILOMETER TEST; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; IN VITRO STUDY; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; DRUG EFFECTS; GRAM NEGATIVE INFECTION; HUMAN; METABOLISM; MICROBIOLOGY;

ANTI-BACTERIAL AGENTS; AZABICYCLO COMPOUNDS; AZTREONAM; BETA-LACTAMASES; CEFTAZIDIME; DRUG SYNERGISM; ENTEROBACTERIACEAE; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; PSEUDOMONAS AERUGINOSA; SERINE;

EID: 85020284258     PISSN: 07328893     EISSN: 18790070     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2017.05.009     Document Type: Article

References (8)

1. Avycaz (ceftazidime/avibactam) prescribing information. 2015, Actavis, Inc. [Available at http://pi.actavis.com/data_stream.asp?product_group=1957&p=pi&language=E. Accessed 14 September 2015].
2. Clinical and Laboratory Standards Institute (CLSI), Performance standards for antimicrobial susceptibility testing: Approved twenty-sixth edition: Document M100-S26. 2016, CLSI, Wayne, PA, USA.
3. Doern, C.D., When does 2 plus 2 equal 5? A review of antimicrobial synergy testing. J Clin Microbiol 52 (2014), 4124–4128.
4. Fleiss, J.L., Levin, B., Cho, Paik M., Statistical methods for rates and proportions. 3rd ed., 2003, Wiley, Hoboken, NJ.
5. Pankey, G.A., Ashcraft, D.S., In vitro synergy of ciprofloxacin and gatifloxacin against ciprofloxacin-resistant Pseudomonas Aeruginosa. Antimicrob Agents Chemother 49 (2005), 2959–2964.
6. Pankey, G.A., Ashcraft, D.S., Dornelles, A., Comparison of 3 Etest((R)) methods and time-kill assay for determination of antimicrobial synergy against carbapenemase-producing Klebsiella species. Diagn Microbiol Infect Dis 77 (2013), 220–226.
7. Sopirala, M.M., Mangino, J.E., Gebreyes, W.A., Biller, B., Bannerman, T., Balada-Llasat, J.M., et al. Synergy testing by Etest, microdilution checkerboard, and time-kill methods for pan-drug-resistant Acinetobacter Baumannii. Antimicrob Agents Chemother 54 (2010), 4678–4683.
8. Zasowski, E.J., Rybak, J.M., Rybak, M.J., The beta-lactams strike back: ceftazidime-avibactam. Pharmacotherapy 35 (2015), 755–770.